Details
Stereochemistry | ABSOLUTE |
Molecular Formula | 2C16H17NO3.3H2O |
Molecular Weight | 596.668 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 10 / 10 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O.O.O.[H][C@@]12OC3=C4C(C[C@@]5([H])NCC[C@@]14[C@@]5([H])C=C[C@@H]2O)=CC=C3O.[H][C@@]67OC8=C9C(C[C@@]%10([H])NCC[C@@]69[C@@]%10([H])C=C[C@@H]7O)=CC=C8O
InChI
InChIKey=CSKBTWFSQKIQRF-WPAPNCBNSA-N
InChI=1S/2C16H17NO3.3H2O/c2*18-11-3-1-8-7-10-9-2-4-12(19)15-16(9,5-6-17-10)13(8)14(11)20-15;;;/h2*1-4,9-10,12,15,17-19H,5-7H2;3*1H2/t2*9-,10+,12-,15-,16-;;;/m00.../s1
Normorphine is an opiate analog, specifically the N-demethylated derivative of morphine. It was first described in the 1953 as part of an effort to characterize N-substituted morphine analogs. Normorphine has relatively little opioid activity, but it is a useful intermediate for the production of more potent morphine analogs. It is also a major metabolite of morphine.
CNS Activity
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P35372|||G8XRH8|||Q5TDA1|||Q9UN57 Gene ID: 4988.0 Gene Symbol: OPRM1 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/21396918 |
0.061 µM [Ki] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sources: https://www.ncbi.nlm.nih.gov/pubmed/13588540 |
Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/13539761
Normorphine hydrochloride was administered as a subcutaneous injection to male adult white volunteers as either a single 30 mg/kg dose or seven doses of 9 or 10 mg
Route of Administration:
Parenteral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/21396918
μ-Opioid receptor (MOR) expressing 293T cells were homogenized in 5 mM Tris, 2 mM EDTA, pH 7.4 and centrifuged to extract the cell pellet. The pellet was resuspended in 50 mM of potassium phosphate buffer, pH 7.4. 20 micro-g of membrane protein was mixed with 0.1 - 1 nM of 3H-naloxone, 100 micro-M GTP and various concentrations of normorphine. Samples were incubated for 3 hours, then filtered through a glass fiber filter before liquid scintillation counting. The radioligand binding assay determined the initial affinity of normorphine for the μ-opioid receptor; a Ki of 0.063 μM was reported.
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
m8070
Created by
admin on Sat Dec 16 08:29:35 GMT 2023 , Edited by admin on Sat Dec 16 08:29:35 GMT 2023
|
PRIMARY | |||
|
DTXSID60975760
Created by
admin on Sat Dec 16 08:29:35 GMT 2023 , Edited by admin on Sat Dec 16 08:29:35 GMT 2023
|
PRIMARY | |||
|
J6061U34KH
Created by
admin on Sat Dec 16 08:29:35 GMT 2023 , Edited by admin on Sat Dec 16 08:29:35 GMT 2023
|
PRIMARY | |||
|
5492888
Created by
admin on Sat Dec 16 08:29:35 GMT 2023 , Edited by admin on Sat Dec 16 08:29:35 GMT 2023
|
PRIMARY | |||
|
6035-32-1
Created by
admin on Sat Dec 16 08:29:35 GMT 2023 , Edited by admin on Sat Dec 16 08:29:35 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD